The NIBIT-M1 trial: Activity of ipilimumab plus fotemustine in patients with melanoma and brain metastases

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2012
This article has no abstract
Epistemonikos ID: 6423d96dcd0d5c0a04c1728883ff41de0ba993d8
First added on: Feb 05, 2025